close read more

Appointment of Angelo Paci, Oncology & Immuno-Oncology Program Leader


Appointment of Angelo Paci, Oncology & Immuno-Oncology Program Leader

Angelo Paci, PharmD, PhD, was appointed Oncology & Immuno-Oncology Program Leader for the Servier Group. He will contribute to the early development of drugs in oncology and will play a leading role in supporting drug reformulation efforts in pediatric oncology. 

“I am very pleased to welcome Angelo Paci whose scientific expertise in the field of oncology is internationally recognized. He will be a major contributor to the Group’s ambitions in the field of Oncology and Immuno-Oncology,” said Walid Kamoun, Director of Oncology R&D at Servier.

“I am delighted to join Servier and look forward to collaborating with an international team of experts, working with and for patients, to provide innovative therapeutic solutions,” added Angelo Paci.

With 20 years of academic and hospital experience focused on oncology, Angelo has led numerous preclinical, translational and clinical projects.

To know more, read the press release

Appointment of Walid S. Kamoun, PhD. MSc., Global Head of Servier R&D Oncology

Last news

Meeting the challenge of adherence: a Servier study presented at the ESH 2022 Annual Meeting!
Patient associations’ perception of pharmaceutical companies: Servier is making progress!
“For a positive and lasting impact”: discover the 2022 CSR publication